When it comes to cosmeceuticals and advanced skincare offered by physicians you want to make sure that the products’ efficacy is fully supported by clinical studies. Enter ReGenica by Suneva Medical, Inc., a three product line powered by growth factor proteins, which has three studies to support its benefits.
“Just because something sounds scientific doesn’t mean it is scientific,” said New York dermatologist Heidi Waldorf, M.D., at the recent launch event in New York City that introduced ReGenica to the media and medical community. Sales of cosmeceuticals—a word that is a hybrid of cosmetics and pharmaceutical—grew nearly 30% from 2008 to 2011, reported Dr. Waldorf. And since they are considered beauty products and not drugs, cosmeceuticals are not subject to FDA rigor.
ReGenica, on the other hand, has three clinical studies to support its efficacy—one that proves its anti-aging benefits and two to show its effects when applied after laser rejuvenation treatments.
“Decades of research about growth factors have gone into the development of ReGenica,” said Dr. Gail Naughton, a regenerative medicine scientist, who created the proprietary tissue engineering technology in the line. Dr. Naughton’s experience is unparalleled—she is the inventor of the key ingredient in TNS®, the growth factor blend in SkinMedica products.
The ReGenica line comprises Advanced Rejuvenation Day Repair SPF 15 ($175), Advanced Rejuvenation Overnight Repair ($175), and Facial Rejuvenation Complex Post Procedure ($150). Day Repair and Night Repair fight signs of aging including fine lines, wrinkles, irregular pigmentation, and roughness. Post Procedure is formulated to speed up and enhance recovery after a facial laser treatment.
The products all feature the next generation of growth factor called Multipotent CCM Complex. The complex contains a variety of embryonic-like proteins and growth factors that are characteristic of young, rapidly developing tissue and associated with skin rejuvenation.
The incredible healing capacity of fetuses inspired Dr. Naughton to focus on turning cells back to an embryonic state. “What really intrigued me about wound healing, and still does is that you can do any surgery on a fetus or embryo and it will be born without a scar,” said Dr. Naughton.
The embryonic-like growth factors in the complex are the result of a laboratory process that causes cells to mimic human embryonic conditions.
The three ReGenica studies support the effectiveness of the Multipotent CCM Complex. A controlled anti-aging study, conducted over 10 weeks, asked participants to use ReGenica Day in the morning and Overnight Repair at night. Users saw a 50% increase in moisture and 64% reported more radiant skin after 10 weeks. In addition, 82% had improved skin texture, 90% had a decrease in pore size, and skin elasticity was improved by 23%.
Two post-laser clinical studies proved the impact of ReGenica Facial Rejuvenation Complex Post Procedure in reducing redness and promoting healing. In a split-face study of subjects who had an ablative (deep skin) laser treatment, patients saw improved healing and more rapid re-epithelialization as early as three days after the laser procedure using the Facial Rejuvenation Complex Post Procedure.
Featuring a light-citrus fragrance, the ReGenica products are absorbed quickly and go on smoothly, so you can apply makeup easily after application. The product line is exclusively available through physician offices. For more information, visit www.regenica.com.
- MEET SONIA KHEMIRI AND SYLVIE GIRET – CO-FOUNDERS OF BEAUTYQUE NYC
- SPONSORED: SHOPBOP SUMMER SALE IS HERE!
- MEET DR. LARA DEVGAN – BOARD CERTIFIED PLASTIC SURGEON AND REALSELF CHIEF MEDICAL EDITOR
- MEET DR. ROBERT MORIN – PLASTIC SURGEON, CRANIOFACIAL SURGEON AND PEDIATRIC PLASTIC SURGEON
- #STAYTHEFHOME – TRY THESE NEW K-BEAUTY PRODUCTS